aCGH Impacts Survival in Plasma Cell PTLD

Post-transplantation Lymphoproliferative Disorders Clinical Trial

Official title: Array-CGH in Plasma Cell Post-transplantation Lymphoproliferative Disorders

Status Completed

Clinical Trial Summary

Plasma-cell post-transplantation lymphoproliferative disorders (PC-PTLD) are rare monomorphic PTLD divided into plasma cell myeloma (PCM) and plasmacytoma-like lesion (PLL) PTLD. To date, there is no exhaustive published cytogenetic data on PC-PTLD. The investigators report array-based comparative genomic hybridization (aCGH) of 10 cases of PCM and PLL-PTLD.

Clinical Trial Description

n/a

Study Design

Time Perspective: Retrospective

Related Conditions & MeSH terms

• Lymphoproliferative Disorders
• Post-transplantation Lymphoproliferative Disorders

• NCT number: NCT02984215
• Study type: Observational
• Source: Hospices Civils de Lyon
• Status: Completed
• Phase: N/A
• Start date: January 1990
• Completion date: June 2016